Short Interest in Defence Therapeutics Inc. (OTCMKTS:DTCFF) Drops By 5.6%

Defence Therapeutics Inc. (OTCMKTS:DTCFF) was the recipient of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,700 shares, a drop of 5.6% from the May 15th total of 1,800 shares. Based on an average daily volume of 300 shares, the short-interest ratio is presently 5.7 days.

Defence Therapeutics Price Performance

OTCMKTS:DTCFF opened at $0.83 on Tuesday. The company has a 50 day moving average price of $0.93 and a 200-day moving average price of $1.31. Defence Therapeutics has a 1-year low of $0.81 and a 1-year high of $3.19.

Defence Therapeutics Company Profile

Defence Therapeutics Inc engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments.